EPISODE · Jan 9, 2025 · 22 MIN

Dave Ricks

from The David Rubenstein Show · host Bloomberg

Eli Lilly is the world's most valuable drug company, known for its blockbuster anti-obesity drugs that's transforming America. In an episode of "The David Rubenstein Show: Peer to Peer Conversations," CEO Dave Ricks talks about how the company will begin studies this year to see if its weight-loss medicines can also be used to treat addictive behaviors like alcohol abuse, smoking and drug addiction. He also discusses how the company is tackling the issue of counterfeit drugs, as well as the other projects they have on the pipeline. This interview was recorded on December 10 at the Economic Club of Washington DC. See omnystudio.com/listener for privacy information.

Episode metadata supplied by the publisher feed · Published Jan 9, 2025

Embed this episode

Attribution link and audio player

NOW PLAYING

Dave Ricks

0:00 22:38

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of The David Rubenstein Show?

This episode is 22 minutes long.

When was this The David Rubenstein Show episode published?

This episode was published on January 9, 2025.

Is there a transcript available for this episode?

Yes, a full transcript is available for this episode. You can read the complete transcript on the episode page.

Can I download this The David Rubenstein Show episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!